Proteome Sciences (LON:PRM) Issues Earnings Results

Proteome Sciences (LON:PRM – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported GBX (0.41) EPS for the quarter, Digital Look Earnings reports. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

Proteome Sciences Stock Performance

Shares of PRM stock traded up GBX 0.12 during trading hours on Wednesday, hitting GBX 1.57. The stock had a trading volume of 484,540 shares, compared to its average volume of 374,589. The firm has a market capitalization of £5.51 million, a PE ratio of -1.51 and a beta of 0.16. The stock’s 50 day moving average is GBX 1.72 and its 200 day moving average is GBX 1.64. The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. Proteome Sciences has a twelve month low of GBX 1.11 and a twelve month high of GBX 4.40.

Get Proteome Sciences alerts:

Proteome Sciences Company Profile

(Get Free Report)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.

Further Reading

• Five stocks we like better than Proteome Sciences
• Qualcomm’s Discount Could Vanish If Its AI Bet Pays Off
• Micron’s AI Memory Boom Could Send Shares 100% Higher
• Apple Stock Surges After Its Biggest Product Launch in Years—Can It Last?
• The Ultimate Cyber Shield: CrowdStrike Rises Past $235

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.